柳叶刀 (2023年第401卷第10382-10386期)
一、01 April 2023-Volume 401-Issue 10382(2023年4月1日第401卷第10382期)
https://www.thelancet.com/journals/lancet/issue/vol401no10382/PIIS0140-6736(23)X0013-0
1. 遗传性血管水肿:是否有更好的治疗前景?
(Hereditary angioedema: is there a better future for treatment?)
作者:Delphine Gobert, Nicolas Javaud*(Sorbonne Université, France; Université Paris Cité, France)
2. 神经激肽3受体拮抗剂治疗绝经期血管舒缩症
(Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms)
作者:Julia K Prague(University of Exeter, UK)
3. 一种用于遗传性血管水肿预防的XIIa因子抑制剂——garadacimab的有效性和安全性(VANGUARD):一项全球、多中心、随机、双盲、安慰剂对照的3期试验
(Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial)
作者:Avner Reshef, Prof Timothy J Craig*(Barzilai University Hospital, Ashkelon, Israel; Penn State University, USA)
4. 非唑奈坦治疗与更年期相关的中重度血管舒缩症状(天窗1):一项3期随机对照研究
(Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study)
作者:Samuel Lederman, Prof Genevieve Neal-Perry* (Altus Research, Lake Worth, FL, USA; University of North Carolina School of Medicine, USA)
二、08 April 2023-Volume 401-Issue 10383(2023年4月8日第401卷第10383期)
https://www.thelancet.com/journals/lancet/issue/vol401no10383/PIIS0140-6736(23)X0014-2
1. 鞘氨醇-1-磷酸受体激动剂依曲莫德治疗溃疡性结肠炎
(The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitis)
作者: Markus F Neurath, Raja Atreya*(Erlangen University Hospital, Germany)
2. BRIGHT-4试验:比伐卢定有反作用
(BRIGHT-4 trial: bivalirudin strikes back)
作者:Thibaut Manigold, Pierre-Guillaume Piriou*(L'institut du thorax, Nantes Université, France)
3. BRIGHT-4试验:比伐卢定有反作用——作者回复
(BRIGHT-4 trial: bivalirudin strikes back – Authors' reply)
作者:Yi Li, Yaling Han*(General Hospital of Northern Theater Command, China)
4. 依曲莫德用于溃疡性结肠炎的诱导和维持治疗(ELEVATE):两项随机、双盲、安慰剂对照、3期研究
(Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies)
作者:Prof Séverine Vermeire, Prof William J Sandborn*(University Hospitals Leuven, Belgium; University of California San Diego, USA)
三、15 April 2023-Volume 401-Issue 10384(2023年4月15日第401卷第10384期)
https://www.thelancet.com/journals/lancet/issue/vol401no10384/PIIS0140-6736(23)X0015-4
1. 炎症会增加接受他汀类药物治疗患者的心血管风险
(Inflammation contributes to cardiovascular risk in patients receiving statin therapy)
作者:Michelle Samuel, Jean-Claude Tardif*(Montreal Heart Institute, Canada)
2. 根除幽门螺杆菌和阿司匹林:一个尚未解决的困惑
(Helicobacter pylori eradication and aspirin: a puzzle yet to be solved)
作者:Luigi Gatta(Nuovo Regina Margherita Hospital, Italy; Versilia Hospital, Italy)
3. 根除幽门螺杆菌和阿司匹林:一个尚未解决的困惑——作者回复
(Helicobacter pylori eradication and aspirin: a puzzle yet to be solved – Author's reply)
作者:Chris Hawkey(School of Medicine, University of Nottingham, UK)
4. 含蒽环类和紫杉类药物的化疗治疗早期可手术乳腺癌:一项来自86项随机试验的10万名女性患者水平的荟萃分析
(Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials)
作者:Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
四、22 April 2023-Volume 401-Issue 10385(2023年4月22日第401卷第10385期)
https://www.thelancet.com/journals/lancet/issue/vol401no10385/PIIS0140-6736(23)X0016-6
1. 青蒿琥酯与奎宁:对照试验的分水岭
(Artesunate versus quinine: the controlled trials watershed)
作者:Conrad Keating(School of Medicine, Trinity College Dublin, Ireland)
五、29 April 2023-Volume 401-Issue 10386(2023年4月29日第401卷第10386期)
https://www.thelancet.com/journals/lancet/issue/vol401no10386/PIIS0140-6736(23)X0017-8
1. 预防血友病A或血友病B伴抑制剂患者的fitusiran,其疗效和安全性(ATLAS-INH):一项多中心、开放标签、随机3期试验
(Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial)
作者:Alok Srivastava, Guy Young*(Christian Medical College & Centre for Stem Cell Research, India; University of Southern California, USA)
- 1国际TOP10医学期刊药物治疗信息 (2024年2月)2024-03-12 08:47:07
- 2国际TOP10药学期刊文章信息 (2024年2月)2024-03-11 11:42:42
- 3治疗药物监测杂志文章信息(2024年第46卷第1期)2024-02-26 13:25:52
- 4国际TOP10医学期刊药物治疗信息 (2024年1月)2024-02-06 10:02:48
- 5国际TOP10药学期刊文章信息 (2024年1月)2024-02-05 07:55:30
- 6治疗药物监测杂志文章信息(2023年第45卷第6期)2024-01-10 08:34:12
- 7国际TOP10医学期刊药物治疗信息 (2023年12月)2024-01-08 14:34:41
- 8国际TOP10药学期刊文章信息 (2023年12月)2024-01-05 14:43:14
- 9国际TOP10医学期刊药物治疗信息(2023年11月)2023-12-14 12:22:30
- 10中国药师协会治疗药物监测药师分会于12月10日完成换届(附第二届委员名单)2023-12-11 16:10:33